Literature DB >> 32693755

Relationship between Gut Microbiota, Gut Hyperpermeability and Obesity.

Amin Gasmi1, Pavan Kumar Mujawdiya2, Lyudmila Pivina3, Alexandru Doşa4, Yuliya Semenova3, Asma Gasmi Benahmed5, Geir Bjørklund6.   

Abstract

Intestinal hyperpermeability is a complex metabolic process mediated by different pathways in close relation to the gut microbiota. Previous studies suggested that the gut microbiota is involved in different metabolic regulations, and its imbalance is associated with several metabolic diseases, including obesity. It is well known that intestinal hyperpermeability is associated with dysbiosis, and the combination of these two conditions can lead to an increase in the level of low-grade inflammation in obese patients due to an increase in pro-inflammatory cytokine levels. Inflammatory bowel syndrome often accompanies this condition causing an alteration of the intestinal mucosa and thus reinforcing the dysbiosis and gut hyperpermeability. The onset of metabolic disorders depends on violations of the integrity of the intestinal barrier as a result of increased intestinal permeability. Chronic inflammation due to endotoxemia is responsible for the development of obesity. Metabolic disorders are associated with dysregulation of the microbiota-gut-brain axis and with an altered composition of gut flora. In this review, we will discuss the mechanisms that illustrate the relationship between hyperpermeability, the composition of the gut microbiota, and obesity. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Gut microbiota; gut inflammation; intestinal hyperpermeability; metabolic; metabolic regulation; obesity

Mesh:

Year:  2021        PMID: 32693755     DOI: 10.2174/0929867327666200721160313

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  7 in total

Review 1.  From Gut Microbiota through Low-Grade Inflammation to Obesity: Key Players and Potential Targets.

Authors:  Claudia Vetrani; Andrea Di Nisio; Stavroula A Paschou; Luigi Barrea; Giovanna Muscogiuri; Chiara Graziadio; Silvia Savastano; Annamaria Colao
Journal:  Nutrients       Date:  2022-05-18       Impact factor: 6.706

2.  The Zonulin-transgenic mouse displays behavioral alterations ameliorated via depletion of the gut microbiota.

Authors:  Alba Miranda-Ribera; Gloria Serena; Jundi Liu; Alessio Fasano; Marcy A Kingsbury; Maria R Fiorentino
Journal:  Tissue Barriers       Date:  2021-11-14

Review 3.  Role of metabolites derived from gut microbiota in inflammatory bowel disease.

Authors:  Lie Zheng; Xin-Li Wen; Sheng-Lei Duan
Journal:  World J Clin Cases       Date:  2022-03-26       Impact factor: 1.337

4.  Anti-Obesity and Gut Microbiota Regulation Effects of Phospholipids from the Eggs of Crab, Portunus Trituberculatus, in High Fat Diet-Fed Mice.

Authors:  Laijin Su; Hongli Zhu; Sichun Chen; Mengyu Du; Xiaofeng Wan; Yishu Liu; Shiwei Hu; Yangli Xu
Journal:  Mar Drugs       Date:  2022-06-23       Impact factor: 6.085

5.  Analysis of the Relationship between Gut Flora Levels in Childhood Obese Population and Normal Healthy Population Based on Machine Learning.

Authors:  Yaoqing Feng; Xia Si; Ruifang Zhu; Junxiang Chen; Wenting Zhao; Qian Wang; Shifan Han
Journal:  Comput Math Methods Med       Date:  2022-08-28       Impact factor: 2.809

Review 6.  Importance of the endometrial immune environment in endometrial cancer and associated therapies.

Authors:  Hannah van der Woude; Kathryn Elizabeth Hally; Margaret Jane Currie; Olivier Gasser; Claire Elizabeth Henry
Journal:  Front Oncol       Date:  2022-08-22       Impact factor: 5.738

7.  The Herb Pair Radix Rehmanniae and Cornus Officinalis Attenuated Testicular Damage in Mice With Diabetes Mellitus Through Butyric Acid/Glucagon-Like Peptide-1/Glucagon-Like Peptide-1 Receptor Pathway Mediated by Gut Microbiota.

Authors:  Yuping Chen; Siyuan Song; Anmei Shu; Liping Liu; Jinjin Jiang; Ming Jiang; Qin Wu; Huiqin Xu; Jihu Sun
Journal:  Front Microbiol       Date:  2022-02-22       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.